ly 255283 has been researched along with Acute Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, MP; Larkin, V; Menconi, MJ; O'Sullivan, BP; Wang, H; Wollert, PS | 1 |
1 other study(ies) available for ly 255283 and Acute Disease
| Article | Year |
|---|---|
LY255283, a novel leukotriene B4 receptor antagonist, limits activation of neutrophils and prevents acute lung injury induced by endotoxin in pigs.
Topics: Acute Disease; Animals; Dose-Response Relationship, Drug; Lipopolysaccharides; Male; Neutrophils; Receptors, Immunologic; Receptors, Leukotriene B4; Respiratory Distress Syndrome; Swine; Tetrazoles | 1993 |